# Cellentra Viable Cell Bone Matrix (VCBM) Anterior Cervical Discectomy and Fusion Outcomes Study (VCBM/MaxAn)

> **NCT02182843** · NA · COMPLETED · sponsor: **Zimmer Biomet** · enrollment: 81 (actual)

## Conditions studied

- Cervical Disc Degenerative Disorder

## Interventions

- **BIOLOGICAL:** Cellentra VCBM

## Key facts

- **NCT ID:** NCT02182843
- **Lead sponsor:** Zimmer Biomet
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2019-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02182843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02182843, "Cellentra Viable Cell Bone Matrix (VCBM) Anterior Cervical Discectomy and Fusion Outcomes Study (VCBM/MaxAn)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02182843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*